APLM (APLM) Stock Price & Analysis
APLM (APLM) fell 10.89% to USD 24.5 as of September 9, 2026 at 00:07 UTC, according to Nexqual real-time market data.
APLM last closed at USD 24.5; the session ranged USD 22.87–27.37 on volume of 65,833 shares. Market capitalization is —, with a 52-week range of USD 5.61–42.12 (NCM). Source: Nexqual, September 9, 2026 at 00:07 UTC.
Key Statistics (as of September 9, 2026 at 00:07 UTC)
| Price | USD 24.5 |
|---|---|
| Change | ▼ 10.89% (down) |
| Previous Close | USD 24.5 |
| Open | USD 24.5 |
| Day Range | USD 22.87 – 27.37 |
| 52-Week Range | USD 5.61 – 42.12 |
| Volume | 65,833 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (APLM)
Nexqual's technical model rates APLM "BUY" based on 5 bullish and 2 bearish signals across 126 daily candles, as of September 9, 2026 at 00:07 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 72.31 (overbought) |
| vs SMA50 | Above (USD 20.69) |
| MACD | 2.33 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.96 | ▲ 7.1% |
| ZVSA | ZyVersa Therapeutics, Inc. | USD 0.1 | ▲ 0% |
| ICU | SeaStar Medical Holding Corpora | USD 2.95 | ▲ 1.37% |
| BGLC | BioNexus Gene Lab Corp | USD 1.4 | ▼ 4.76% |
| BDRX | Biodexa Pharmaceuticals plc | USD 0.83 | ▲ 4.14% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 00:07 UTC. This page is informational and not investment advice.